Vilma P. Barcia MD, PhD, MSc· @DrVilmaPBarcia · X·· 16 小时前评分70
正文 · 原文
🚨 #ESMO26 Plenary | HARMONi-GI1
Ivonescimab + chemo improves outcomes vs durvalumab + chemo in 1L advanced BTC 🇨🇳
- OS: 14.9 vs 12.1 mo (HR 0.75)
- PFS: 8.4 vs 5.8 mo (HR 0.61)
- ORR: 53.8% vs 32.5%
@OncoAlert #GIOncology @myESMO
18 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Vilma P. Barcia MD, PhD, MSc · x.com